FEATURED INSIGHTS

• Decoding AAV: Navigating Critical Quality Attributes And Their Analytics

  For groundbreaking genetic treatments, stringent quality control is non-negotiable. This exploration delves into defining essential attributes and the analytical tools that safeguard their consistent production.

• Understanding EndoCleave's Role In Viral Vector Manufacturing

  Achieving high-quality viral vectors demands rigorous control over contaminants. Learn about enzymatic approaches to significantly reduce nucleic acid impurities in your manufacturing processes.

• In Vitro Glycoengineering (IVGE): Taking Control Of Glycosylation

  Discover how to gain precise control over one of the most common and critical forms of protein modification for therapeutic benefit and stability.

• The Evolution Of Nucleotide Production

  From harsh chemicals to gentle enzymes: Explore the groundbreaking shift in nucleotide synthesis, making drug manufacturing cleaner, greener, and more efficient.

• Navigating The Regulatory Landscape For mRNA-Based Therapeutics Post-COVID

  While organizations adapt to evolving safety and efficacy standards for mRNA, collaboration remains essential for navigating challenges like differing regional requirements, higher dosing needs, and analytical complexities.

• Essential Strategies For IVT Optimization

  Optimizing in vitro transcription (IVT) for mRNA is crucial to improving the stability of these molecules and enabling their large-scale production.

• Defining The Necessary Steps In Antibody Development

  Explore antibody development and production, the processes and steps involved, and the screening and selection of antibody candidates.

• Optimized Performance Model For Yield And Quality Of The mRNA Product

  Optimize your mRNA production by identifying an optimum set of conditions for the IVT reaction that produces high-quality mRNA in high yield using a design of experiment (DoE) approach.

• Preparing For An Imminent Transformation In How We Treat Diseases

  Learn what some practical considerations are for implementing NAT-based methods, where concrete recommendations are necessary, and how guidelines can remain relevant for new medicinal products.

• Advances In High-Throughput Upstream Process Development

  Explore temperature effects on product titer, automated cell culture development workflow, maximizing product life-cycle efficiency with the right DOE strategy, and effective data management.

• A Smart Path For Novel Biologics

  Learn about a solution for streamlining workflow in novel biologics while collecting quality data, by combining single-use microbioreactors with advanced automation and analytical platforms.